Literature DB >> 1312539

The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression.

M Lauritzen1, A J Hansen.   

Abstract

We examined the effect of blockade of N-methyl-D-aspartate (NMDA) and non-NMDA subtype glutamate receptors on anoxic depolarization (AD) and cortical spreading depression (CSD). [K+]e and the direct current (DC) potential were measured with microelectrodes in the cerebral cortex of barbiturate-anesthetized rats. NMDA blockade was achieved by injection of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate [MK-801; 3 and 10 mg/kg] or amino-7-phosphonoheptanoate (APH; 4.5 and 10 mg/kg). Non-NMDA receptor blockade was achieved by injection of 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline (NBQX; 10 and 20 mg/kg). MK-801 and APH blocked CSD, while NBQX did not. In control rats, the latency from circulatory arrest to AD was 2.1 +/- 0.1 min, while the amplitude of the DC shift was 21 +/- 1 mV, and [K+]e increased to 50 +/- 6 mM. All variables remained unchanged in animals treated with MK-801, APH, or NBQX. Finally, MK-801 (14 mg/kg) and NBQX (40 mg/kg) were given in combination to examine the effect of total glutamate receptor blockade on AD. This combination slightly accelerated the onset of AD, probably owing to circulatory failure. In conclusion, AD was unaffected by glutamate receptor blockade. In contrast, NMDA receptors play a crucial role for CSD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312539     DOI: 10.1038/jcbfm.1992.32

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  58 in total

1.  Osmotic forces and gap junctions in spreading depression: a computational model.

Authors:  B E Shapiro
Journal:  J Comput Neurosci       Date:  2001 Jan-Feb       Impact factor: 1.621

Review 2.  Experimental models, neurovascular mechanisms and translational issues in stroke research.

Authors:  E H Lo
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

Review 3.  Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury.

Authors:  Martin Lauritzen; Jens Peter Dreier; Martin Fabricius; Jed A Hartings; Rudolf Graf; Anthony John Strong
Journal:  J Cereb Blood Flow Metab       Date:  2010-11-03       Impact factor: 6.200

4.  PSD-95 uncoupling from NMDA receptors by Tat- N-dimer ameliorates neuronal depolarization in cortical spreading depression.

Authors:  Krzysztof Kucharz; Ida Søndergaard Rasmussen; Anders Bach; Kristian Strømgaard; Martin Lauritzen
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

5.  Mechanisms of the negative potential associated with Leão's spreading depolarization: A history of brain electrogenesis.

Authors:  Oscar Herreras; Julia Makarova
Journal:  J Cereb Blood Flow Metab       Date:  2020-06-24       Impact factor: 6.200

6.  Neuronal cyclooxygenase-2 activity and prostaglandins PGE2, PGD2, and PGF2 alpha exacerbate hypoxic neuronal injury in neuron-enriched primary culture.

Authors:  Wenjin Li; Shasha Wu; Robert W Hickey; Marie E Rose; Jun Chen; Steven H Graham
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

Review 7.  Mechanisms involved in the cerebrovascular dilator effects of N-methyl-d-aspartate in cerebral cortex.

Authors:  David W Busija; Ferenc Bari; Ferenc Domoki; Thomas Louis
Journal:  Brain Res Rev       Date:  2007-06-12

Review 8.  Cortical spreading depression and migraine.

Authors:  Andrew C Charles; Serapio M Baca
Journal:  Nat Rev Neurol       Date:  2013-09-17       Impact factor: 42.937

9.  Neuronal mechanisms of the anoxia-induced network oscillations in the rat hippocampus in vitro.

Authors:  V Dzhala; I Khalilov; Y Ben-Ari; R Khazipov
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

10.  Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex.

Authors:  T P Obrenovitch; E Zilkha
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.